Noscapine

An alkaloid.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

3
Supporting references
0
Contradictory references
3
AI-suggested references
0
Clinical trials

General information

Noscapine is a non-narcotic alkaloid from Papaver somniferum. It displays antitussive and mild analgesic activity. Noscapine has been studies for potential antineoplastic activity, which could be due to its capability to inhibit mitosis via tubulin binding. This could in turn lead to tumour cell death (NCIt).

Noscapine on DrugBank
Noscapine on PubChem
Noscapine on Wikipedia

 

Structure image - Noscapine

CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3


Supporting references

Link Tested on Impact factor Notes Publication date
Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro
Small molecule In vitro
Vero E6 cells; Calu-3 cells 4.15

less potent than Remdesivir

Nov/26/2020
Molecular binding mechanism and pharmacology comparative analysis of noscapine for repurposing against SARS-CoV-2 protease
Small molecule In silico
in silico 4.07

Predicted to bind SARS-CoV-2 3C-like protease close to the binding pocket-3.

Aug/06/2020
Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis
3CLpro Small molecule In silico
in silico 3.31

Conjugated with hydroxychloroquine is predicted to inhibit SARS-CoV-2 3C-like protease.

Aug/20/2020

AI-suggested references